NTI Horizon Scan Helps Leaders Anticipate Fast‑Moving AIxBio Advances
With AIxBio tools advancing faster than many experts predicted, new AIxBio Horizon Scan provides early insights to support stronger safety, security, and governance decisions.
AIxBio Horizon Scan Winter 2025-2026
The AIxBio field stands at a critical juncture where rapid capability advances are outpacing governance frameworks and safety measures. The next 18 months will likely prove pivotal in determining whether voluntary safety practices by AI companies, emerging evaluation frameworks, and international coordination efforts can keep pace with technological development.
A Critical Moment for AIxBio Safety and Security
The convergence of artificial intelligence and the life sciences is reshaping what’s possible in biology, delivering major advances–ranging from accelerating vaccine discovery to advancing new tools for mitigating the effects of climate change–and new risks. NTI | bio’s AIxBio Horizon Scan looks ahead to where AIxBio capabilities are headed over the coming years.
NTI Welcomes Jake Jordan to Lead NTI | bio
The Nuclear Threat Initiative (NTI) announces the appointment of Jake Jordan, PhD as vice president of Global Biological Policy & Programs (NTI | bio). In this role, Jordan will lead NTI's portfolio of biosecurity projects and advance innovative approaches to strengthen biotechnology governance, reduce the risk of bioweapon development and use, and build global health security capacities.
Article
Jake Jordan, PhD
Jake Jordan, PhD serves as vice president of NTI’s Global Biological Policy and Programs (NTI | bio).
Statement by NTI on the U.S.-Israel Strikes on Iran
The ongoing major combat operations introduce serious nuclear security and proliferation risks.
Article
Simon Thorpe
NTI at the Munich Security Conference: Advancing a Safer Future
The Nuclear Threat Initiative (NTI) joined world leaders and policymakers at the 2026 Munich Security Conference (MSC), where NTI President and CEO Christine E. Wormuth and colleagues hosted events focused on reducing nuclear, biological, and emerging technology threats imperiling humanity.
Managed Access: Preventing AI from Designing Deadly Pathogens
A growing number of the world’s leading experts in health security and the life sciences are warning that unfettered open access to biological data could help AI design dangerous pathogens and are calling for safeguards on high-risk data to prevent misuse of AIxBio tools. Their warnings represent growing momentum behind an idea that NTI has championed: using managed access as a tool to strengthen biosecurity and safeguard rapidly advancing AIxBio capabilities.
Why Responsible AIxBio Innovation Must Be on New Delhi’s Agenda
Some of the world’s largest AI companies—Google DeepMind, OpenAI, and Anthropic—have warned that their models could be misused to cause harm with biology. The India AI Impact Summit is a critical moment for policymakers, scientists, developers, and biosecurity experts to work together on responsible governance that reduces AIxBio risks.